00:42 GMT16 January 2021
Listen Live
    Asia & Pacific
    Get short URL
    3130
    Subscribe

    BEIJING (Sputnik) – China’s National Medical Products Administration authorized on Thursday the public use of the Sinopharm vaccine against the coronavirus, the China Central Television reported.

    On Wednesday, Sinopharm’s subsidiary Beijing Institute of Biological Products said that the efficiency of its vaccine had exceeded 79 percent. The vaccine has already been approved by Bahrain and the United Arab Emirates.

    The scientists will reportedly continue to study the efficiency of the vaccine.

    In this April 11, 2020, photo released by Xinhua News Agency, a staff member tests samples of a potential COVID-19 vaccine at a production plant of SinoPharm in Beijing.
    © AP Photo / Zhang Yuwei
    In this April 11, 2020, photo released by Xinhua News Agency, a staff member tests samples of a potential COVID-19 vaccine at a production plant of SinoPharm in Beijing.

    According to earlier statements of Sinopharm, about 1 million people have already been vaccinated with its drug, including 60,000 people outside China.

    Related:

    EU to Purchase Another 100 Million Doses of Pfizer-BioNTech COVID-19 Vaccine
    Serbia Gets First Batch of Russia's Sputnik V for Vaccinating Citizens Against COVID-19
    Mobilise Mass Vaccination Today!
    Three Moderna Vaccine Shipments to Texas Held Back From Distribution Due to Temperature Issues
    Israeli ‘Tinder Swindler’ Reportedly Pretended to Be Paramedic to Get Early COVID-19 Vaccine Shot
    Tags:
    approval, coronavirus, COVID-19, vaccine, China
    Community standardsDiscussion